<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre‐Antoine Juge, Annick Clément, Dimitrios T. Boumpas et al.|New England Journal of Medicine|2018Cited by 501
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Toby M. Maher, Joyce Lee et al.|American Journal of Respiratory and Critical Care Medicine|2021Cited by 198
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson, Jake G. Natalini, Elana J. Bernstein et al.|Arthritis & Rheumatology|2024Cited by 162
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical StatementAnna J. Podolanczuk, Christopher J. Ryerson, Gary M. Hunninghake et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 78
Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study DesignElizabeth C. Oelsner, Carolina Mendoza‐Puccini, Akshaya Krishnaswamy et al.|American Journal of Epidemiology|2022Cited by 35